In an adult with unstable angina and severe chest pain, should morphine be administered, and if so, what dose and precautions are recommended?

Morphine Use in Unstable Angina

Morphine should be administered in unstable angina when chest pain persists despite nitroglycerin and beta-blocker therapy, using 1-5 mg IV with careful blood pressure monitoring, though its recommendation has been downgraded to Class IIa due to safety concerns from observational data. 1, 2

Indication and Timing

• Morphine is indicated when symptoms are not immediately relieved after 3 sublingual nitroglycerin tablets (taken 5 minutes apart) or when symptoms recur despite adequate anti-ischemic therapy. 2, 3
• It should be administered for ongoing chest pain when acute pulmonary congestion or severe agitation is present. 2
• The recommendation level is Class IIa (Level of Evidence: C) for unstable angina/NSTEMI, which represents a downgrade from the Class I recommendation that applies to STEMI patients. 1

Dosing Protocol

• The recommended dose is 1-5 mg IV, which may be repeated every 5-30 minutes as needed to relieve symptoms and maintain patient comfort. 3
• Alternative dosing from guidelines includes 2-4 mg IV with increments of 2-8 mg repeated at 5-15 minute intervals for STEMI (this same dosing framework can be applied to unstable angina). 1
• The FDA-approved starting dose range is 0.1-0.2 mg/kg every 4 hours, adjusted according to pain severity, adverse events, patient age, and size. 4

Critical Precautions and Monitoring

Blood Pressure Monitoring

• Careful blood pressure monitoring is mandatory, especially when morphine is administered with concurrent intravenous nitroglycerin. 3, 5
• Morphine causes venodilation that decreases cardiac preload and produces modest reductions in systolic blood pressure and heart rate through increased vagal tone. 5, 6
• The hypotensive effect is more pronounced in volume-depleted patients or those on concurrent vasodilator therapy. 5, 7

Management of Hypotension

• Hypotensive reactions typically respond to supine or Trendelenburg positioning, intravenous saline boluses, and atropine when accompanied by bradycardia. 5, 7
• Severe hypotension rarely requires pressors or naloxone to restore blood pressure. 5

Contraindications

• Morphine is contraindicated in patients with known hypersensitivity, bronchial asthma, upper airway obstruction, respiratory depression without resuscitative equipment, and paralytic ileus. 4
• Use with extreme caution in patients with shock or cardiovascular instability. 5, 4

Why the Downgrade in Recommendation?

The recommendation for morphine in unstable angina/NSTEMI was reduced from Class I to Class IIa because retrospective data raised questions about potentially adverse effects in this population. 1

• This contrasts with STEMI, where morphine remains Class I because these patients either have received reperfusion or are not candidates for it, and continuing pain requires relief regardless. 1
• The mechanism of concern relates to morphine's hemodynamic effects potentially masking ongoing ischemia or interfering with antiplatelet therapy absorption, though the guidelines do not specify the exact nature of the adverse effects observed. 1

Therapeutic Rationale

• Morphine provides analgesia while reducing myocardial oxygen demand through venodilation (decreased preload) and modest heart rate reduction. 2, 5, 6
• These hemodynamic benefits are considered therapeutically advantageous in reducing cardiac work, though they must be balanced against the risk of excessive hypotension. 5, 6

Common Pitfalls to Avoid

• Do not use morphine as first-line therapy before attempting nitroglycerin and beta-blockers (unless contraindicated). 2, 3
• Avoid concomitant use with other CNS depressants (benzodiazepines, skeletal muscle relaxants, gabapentinoids) outside highly monitored settings due to increased risk of respiratory depression. 7, 4
• Do not administer rapid IV boluses, as this may result in chest wall rigidity and respiratory depression. 4
• Monitor for nausea/vomiting (occurs in approximately 20% of patients) and have antiemetics available. 7
• Prescribe prophylactic laxative therapy (combination of stool softener and stimulant) as constipation is a common side effect. 7

Respiratory Depression Management

• Naloxone (0.4-2.0 mg IV) is the specific antidote for respiratory depression from morphine overdose and should be immediately available. 7, 4
• Elderly patients require substantially lower starting doses with careful titration and close monitoring due to increased vulnerability to morphine accumulation and over-sedation. 7